首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1627585

攜帶式氧氣濃縮機的全球市場：預測（2025-2030）

Portable Oxygen Concentrator Market - Forecasts from 2025 to 2030

出版日期: 2024年12月20日 | 出版商:

Knowledge Sourcing Intelligence | 英文 141 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

預計2030年全球攜帶式氧氣濃縮機市場規模將達48.69億美元，較2025年的28.60億美元複合年成長率為11.23%。

攜帶式氧氣濃縮機是一種體積小、重量輕、安靜的設備，可以持續為患者提供氧氣。因此，它可以應用於多種領域，包括家庭護理環境、救護車和航空救護車。攜帶式氧氣濃縮機可確保更高的氧氣輸出量，也有助於提高重症患者的存活率。

由於世界各地老年人口的不斷成長，全球市場對攜帶式氧氣濃縮機的需求正在顯著增加，因為它為老年人提供了多種好處，例如預計可以提高他們吸入純氧的能力。隨著人口老化，多種呼吸系統和肺部疾病的風險顯著增加，包括慢性阻塞性肺病（COPD）、氣喘、肺炎和其他肺部疾病。

數字可能有誤：315600000->

世界銀行在《世界人口報告》中指出，到2024年，65歲以上人口總數將達到804,475,000人。這與 2021 年相比顯著增加，當時 65 歲及以上人口總數為 754,681,000 人，到 2022 年將達到約 778,122,000 人。

攜帶式氧氣濃縮機市場促進因素

全球呼吸系統疾病患者數量不斷增加推動市場擴張

全球肺部和呼吸系統疾病病例數量的增加是預測期內推動全球攜帶式氧氣濃縮機市場成長的關鍵因素之一。慢性阻塞性肺病、肺氣腫和慢性支氣管炎等各類呼吸系統和肺部疾病的全球病例在全球範圍內顯著成長。由於污染、年齡和個人生活方式等多種因素，呼吸道疾病病例顯著增加。

美國肺臟協會在報告中指出，美國約有 1,170 萬成年人患有 COPD（慢性阻塞性肺病）。同樣，美國疾病管制與預防中心美國，到 2023 年，美國總人口中約有 4.3% 將被診斷出患有慢性阻塞性肺病、肺氣腫和慢性支氣管炎。此外，因氣喘等慢性呼吸道疾病死亡的人數為147,382人，即每10萬人中有44.2人死亡。肺氣腫和支氣管炎分別導致 7,905 人和 358 人死亡，而其他慢性呼吸道疾病（不包括氣喘）則導致 135,517 人死亡。在日本，因氣喘死亡的人數約為3,602人，相當於每10萬人中有1.1人死亡。

同樣，加拿大統計局在報告中表示，各類呼吸道疾病導致的死亡人數也呈現穩定成長。據該機構稱，2021年該國因呼吸系統疾病死亡的人數為311,640人，2022年將上升至334,081人。同樣，慢性下呼吸道疾病的死亡人數從2021年的11,018人增加到2022年的12,462人。 2023年，將有12,994人死於慢性呼吸道疾病。

印度呼吸系統疾病患者數量在過去幾年也大幅增加。印度市場上肺部和呼吸系統疾病數量增加的主要因素是污染加劇和菸草消費量增加。印度政府國家衛生研究院在報告中指出，印度約25.6%的慢性阻塞性肺病（COPD）病例是由空氣污染引起的，其中煙草約佔總病例的16.5%。此外，根據《印度公共衛生雜誌》報道，印度慢性阻塞性肺病患者人數估計為3,780萬，約佔全球慢性阻塞性肺病患者總數的17.8%。該雜誌也指出，全球約27.3%的慢性阻塞性肺病死亡病例是由本國慢性阻塞性肺病患者造成的。

此外，蘇格蘭公共衛生觀察站在其蘇格蘭公共衛生資訊平台下指出，2018 年至 2023 年間，蘇格蘭的慢性阻塞性肺病病例將大幅增加。該機構進一步指出，在蘇格蘭，男性死於慢性阻塞性肺病的總數為 2.2%，而女性死於慢性阻塞性肺病的死亡率為 2.4%。

攜帶式氧氣濃縮機市場的地理前景：

預計北美將在未來幾年主導市場

攜帶式氧氣濃縮機是慢性阻塞性肺病和肺癌患者長期氧氣療法的重要組成部分，縮小了氧氣溶液的供應和使用之間的差距。對於患有慢性阻塞性肺病和肺癌的患者來說，氧氣濃縮機縮小了獲得和使用氧氣溶液之間的差距，解決這些疾病是美國的主要關注點，並且正在進行各種投資和努力來加強。制定必要的解決方案。

根據肺癌研究基金會的數據，大約 654,620 名美國人將在一生中的某個階段被診斷出患有肺癌，每年導致 125,070 人死亡。同樣，根據美國肺臟協會的《2023 年肺癌狀況報告》，到 2023 年，將有近 238,000 人被診斷出患有肺癌，比 2022 年增加 1,000 人。

此外，老年人更容易患呼吸道和肺部疾病，隨著美國老年人口的不斷成長，被診斷出患有某種類型呼吸道疾病的可能性預計也會增加。根據人口研究所預測，到2050年，65歲以上人口將達到8,200萬，比2022年人口增加47%。因此，消息人士進一步指出，老年人口比例將從17%增加到23%。

然而，多年來肺癌治療的發展已經降低了盛行率，並可能擴大攜帶式氧氣濃縮機的使用。據美國肺癌協會稱，過去五年美國的存活率提高了 26%，聯邦政府正在藉此機會加強癌症篩檢並增加患者獲得所需氧氣溶液的機會。

此外，領先的攜帶式氧氣濃縮機公司正在進軍美國市場，以最佳化不斷成長的商機。例如，根據Inogen Inc.的2023年年報，該公司3.156億美元的收益中，美國貢獻了2.263億美元，佔總收益的近70%。

此外，該公司還投資於新產品的發布，最近的進展包括於 2024 年 10 月在美國市場推出適合家庭護理的 Rove 4攜帶式氧氣濃縮機。在不斷努力降低肺癌患者死亡率之後，這些持續的發展為長期氧氣療法解決方案（例如攜帶式氧氣濃縮機）的未來市場擴張鋪平了道路。

為什麼要購買這份報告？

富有洞察力的分析：獲得涵蓋主要和新興地區的深入市場洞察，重點關注客戶細分、政府政策和社會經濟因素、消費者偏好、行業和其他子區隔。
競爭格局：了解世界主要企業採取的策略策略，並了解透過正確的策略滲透市場的潛力。
市場趨勢和促進因素：探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
可行的建議：利用洞察力做出策略決策，以在動態環境中發現新的業務流和收益。
受眾廣泛：對於新興企業、研究機構、顧問、中小企業和大型企業有用且具有成本效益。

它有什麼用？

產業和市場考量、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響

調查範圍

2022年至2029年的實際資料和預測
成長機會、挑戰、供應鏈前景、法規結構、顧客行為、趨勢分析
競爭定位、策略和市場佔有率分析
區域收益成長和預測分析，包括細分市場和國家
公司簡介（主要是策略、產品、財務資訊、主要動態等）

介紹
北美洲
- 依產品
- 按最終用戶
- 按國家/地區
南美洲
- 依產品
- 按最終用戶
- 按國家/地區
歐洲
- 依產品
- 按最終用戶
- 按國家/地區
中東/非洲
- 依產品
- 按最終用戶
- 按國家/地區
亞太地區
- 依產品
- 按最終用戶
- 按國家/地區

第8章競爭環境及分析

主要企業及策略分析
新興企業和市場盈利
併購/協議/合作
競爭對手儀表板

第9章公司簡介

Precision Medical Inc.
Nidek Medical Products Inc.
Philips Healthcare
Drive DeVilbiss international
Invacare Corporation
Chart Industries
Inogen Inc
Summit Oxygen international
Nareena Lifesciences Private Limited
Anand Medicaids
Hindustan Engineers
Global Medical Devices
EVOX, India

簡介目錄

Product Code: KSI061610973

The portable oxygen concentrator market is estimated to attain US$4.869 billion by 2030, growing at a CAGR of 11.23%, from US$2.860 billion in 2025.

A portable oxygen concentrator is a device which features a small, lightweight, and silent design and offers patients a continuous supply of oxygen. Hence, they offer applicability across multiple sectors, which majorly includes utilization in homecare settings, ambulances, and aero-ambulances. The portable oxygen concentrator ensures a higher oxygen output and it also helps in increasing the survival rate of the critical patients.

The demand for portable oxygen concentrators in the global market is expected to witness a significant increase fuelled with the increasing older population across the world as they offers multiple benefits to the older population such as increasing the body's ability to inhale pure oxygen. With the increasing age of individuals, the risk of various types of respiratory or pulmonary diseases like chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and other type of lung diseases increase drastically.

The World Bank, in its global population report, stated that in 2024, the total population aged 65 years and above was recorded at 804.475 million. This marked a major growth from 2021, when the total population aged 65 and above was recorded at 754.681 million, and about 778.122 million in 2022.

Portable Oxygen Concentrator Market Drivers

Growing global cases of respiratory diseases is propelling the market expansion

The increasing global cases of pulmonary or respiratory diseases are among the key factors propelling the growth of the global portable oxygen concentrator market during the estimated timeline. The global cases of various types of respiratory and lung diseases like COPD, emphysema, and chronic bronchitis witnessed major growth across the globe. The cases of respiratory diseases witnessed a growth majorly caused by various factors like pollution, age, and lifestyle of the individuals.

The American Lung Association in its report stated that in the USA, about 11.7 million adults are affected by COPD or chronic obstructive pulmonary disease. Similarly, the Centers for Disease Control and Prevention of the USA stated that in the nation, about 4.3% of the total population of the nation, in 2023, were diagnosed with COPD, emphysema, or chronic bronchitis. The agency further stated that in the nation, chronic lower respiratory disease, which includes asthma caused about 147,382 deaths, which is equal to about 44.2 deaths per 100,000 population of the nation. The agency stated that emphysema and bronchitis diseases in 2023 caused about 7,905 and 358 deaths respectively, whereas the other chronic lower respiratory diseases which excludes asthma caused 135,517 deaths. In the nation, asthma caused about 3,602 deaths, which is equivalent to 1.1 deaths per 100,000 population.

Similarly, Statistics Canada, in its report stated that the cases of deaths caused by various types of respiratory diseases also witnessed a constant growth. The agency stated that in 2021, about 311,640 deaths in the nation were caused by respiratory disease, which increased to 334,081 in 2022. Likewise, the same source also specified that the deaths caused by chronic lower respiratory diseases increased in the nation from 11,018 deaths in 2021 to 12,462 deaths in 2022. In 2023, the total number of deaths caused by chronic lower respiratory diseases was recorded at 12,994.

The cases of respiratory diseases in India also witnessed significant growth during the past few years. The major factor boosting the cases of pulmonary and respiratory diseases in the Indian market is the increasing pollution and rising consumption of tobacco. The National Institute of Health of the Indian Government in its report stated that air pollution in the nation caused about 25.6% of the total cases of chronic obstructive pulmonary disease or COPD, and tobacco is responsible for about 16.5% of the cases. The Indian Journal of Public Health in its report stated that in India, the total cases of COPD were estimated at 37.8 million. which is about 17.8% of the total global cases. The journal also stated that the cases of COPD in the nation contribute to about 27.3% of the global deaths, caused by COPD.

Furthermore, the Scottish Public Health Observatory under its Public Health Information for Scotland platform stated that in Scotland, the cases of COPD witnessed a major growth from 2018, to 2023. The agency further stated that in the nation, the total deaths caused by COPD in Scotland was recorded at 2.2% for males, whereas the death rate caused by COPD for women was recorded at 2.4%.

Portable Oxygen Concentrator Market Geographical Outlook:

The North America is expected to dominate the market in the coming years

Portable oxygen concentrators form an integral part of long-term oxygen therapy as they reduce the gap between oxygen solutions availability and their usage for patients suffering from chronic obstructive pulmonary disease or lung cancer. Tackling such disease has become a major concern in the United States with various investments and initiatives being undertaken to bolster the development of required solutions.

According to the Lung Cancer Research Foundation, nearly 654,620 Americans have been diagnosed with lung cancer at some point in their lives, and the annual death count reaches up to 125,070 annually. Likewise, according to the "State of Lung Cancer Report 2023' issued by the American Lung Association, nearly 238,000 people were diagnosed with lung cancer in 2023 which represented an increase of 1000 new cases in comparison to 2022.

Moreover, old age people are more prone to respiratory and lung disease and with the constant growth in the geriatric population of the United States, the probability of people getting diagnosed with some form of respiratory disease is also expected to grow. According to the Population Reference Bureau, by 2050 population aged 65 years and above will reach up to 82 million thereby signifying a remarkable growth of 47% over the population recorded in 2022. Hence the same source further specified that the percentage share of old age people will increase from 17% to 23% in the given period.

However, the ongoing developments in lung cancer treatment over the years have reduced the prevalence rate thereby providing a major scope for the usage of portable oxygen concentrators. As per the American Lung Cancer Association, the survival rate of Americans has improved by 26% over the past five years, with the federal government working on opportunities to increase cancer screening and increase access to required oxygen solutions for patients.

Moreover, major players operating in portable oxygen concentrators have established their base in the US market as they aim to optimize the growing opportunity. For instance, as per the 2023 annual report of Inogen Inc. of the total company revenue of US$315.600 million, the United States contributed US$226.3 million thereby constituting nearly 70% of the total revenue.

Furthermore, the company is also investing in new product launches with the recent development being made in October 2024, where the company introduced the "Rove 4" portable oxygen concentrator that is ideal for home care settings in the US market, Additionally, the company, in August 2023, showcased" Rove 6" portable oxygen concentrator in the US. Hence, such ongoing developments followed by constant efforts being made to reduce the mortality rate of lung cancer patients have paved the way for the future market expansion of long-term oxygen therapy solutions such as portable oxygen concentrators.

Reasons for buying this report:-

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data & forecasts from 2022 to 2029
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Portable Oxygen Concentrator Market is analyzed into the following segments:

By Product

Continuous Flow Portable Oxygen concentrator
Pulse Flow Portable Oxygen Concentrator

By End-User

Homecare Setting
Air Ambulance
Others

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Israel
Others
Asia Pacific
China
Japan
South Korea
India
Thailand
Taiwan
Indonesia
Others

1. Introduction

1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits for the Stakeholders

2. Research Methodology

2.1. Research Design
2.2. Research Process
2.3. Data Validation

3. Executive Summary

3.1. Key Findings
3.2. Analyst View

4. Market Dynamics

4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Supplier
- 4.3.2. Bargaining Power of Buyers
- 4.3.3. Threat of New Entrants
- 4.3.4. Threat of Substitutes
- 4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Portable Oxygen Concentrator Market By Product

5.1. Introduction
5.2. Continuous Flow Portable Oxygen Concentrator
5.3. Pulse Flow Portable Oxygen Concentrator

6. Portable Oxygen Concentrator Market By End-User

6.1. Introduction
6.2. Homecare Setting
6.3. Air Ambulance
6.4. Others

7. Portable Oxygen Concentrator Market By Geography

7.1. Introduction
7.2. North America
- 7.2.1. By Product
- 7.2.2. By End-User
- 7.2.3. By Country
  - 7.2.3.1. United States
  - 7.2.3.2. Canada
  - 7.2.3.3. Mexico
7.3. South America
- 7.3.1. By Product
- 7.3.2. By End-User
- 7.3.3. By Country
  - 7.3.3.1. Brazil
  - 7.3.3.2. Argentina
  - 7.3.3.3. Others
7.4. Europe
- 7.4.1. By Product
- 7.4.2. By End-User
- 7.4.3. By Country
  - 7.4.3.1. United Kingdom
  - 7.4.3.2. Germany
  - 7.4.3.3. France
  - 7.4.3.4. Italy
  - 7.4.3.5. Spain
  - 7.4.3.6. Others
7.5. Middle East and Africa
- 7.5.1. By Product
- 7.5.2. By End-User
- 7.5.3. By Country
  - 7.5.3.1. Saudi Arabia
  - 7.5.3.2. UAE
  - 7.5.3.3. Others
7.6. Asia Pacific
- 7.6.1. By Product
- 7.6.2. By End-User
- 7.6.3. By Country
  - 7.6.3.1. China
  - 7.6.3.2. Japan
  - 7.6.3.3. South Korea
  - 7.6.3.4. India
  - 7.6.3.5. Indonesia
  - 7.6.3.6. Thailand
  - 7.6.3.7. Taiwan
  - 7.6.3.8. Others